TNNT2 and cardiovascular disorder: The under-dosage group also had lower heart rates (median 84 vs. 98 bpm, p < 0.005), and higher hs-cTnT levels (25 vs. 16 ng/L, p < 0.005), reflecting a potentially higher burden of cardiovascular disease.